This is an old revision of the document!
Andrew Hill
senior visiting Research Fellow in the Department of Molecular and Clinical Pharmacology at the University of Liverpool (England)
Research
Pandemic Research
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
Ivermectin Efficacy
Presentations
Ivermectin meta-analysis by Dr. Andrew Hill EXTENDED Jan 20, 2021